What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions?

Research output: Contribution to journalEditorial

Original languageEnglish
JournalExpert Opinion on Pharmacotherapy
DOIs
Publication statusPublished - Jan 1 2019

Keywords

  • bremelanotide
  • DHEA
  • female sexual dysfunctions (FSDs)
  • flibanserin
  • hypoactive sexual desire disorder (HSDD)
  • ospemifene
  • Sexual education
  • vulvovaginal atrophy/genitourinary syndrome of menopause (VVA/GSM)

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{5d3ebb03548045ac9d03e5f19a37623c,
title = "What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions?",
keywords = "bremelanotide, DHEA, female sexual dysfunctions (FSDs), flibanserin, hypoactive sexual desire disorder (HSDD), ospemifene, Sexual education, vulvovaginal atrophy/genitourinary syndrome of menopause (VVA/GSM)",
author = "Nappi, {Rossella E.} and Barbara Gardella",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/14656566.2019.1582644",
language = "English",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions?

AU - Nappi, Rossella E.

AU - Gardella, Barbara

PY - 2019/1/1

Y1 - 2019/1/1

KW - bremelanotide

KW - DHEA

KW - female sexual dysfunctions (FSDs)

KW - flibanserin

KW - hypoactive sexual desire disorder (HSDD)

KW - ospemifene

KW - Sexual education

KW - vulvovaginal atrophy/genitourinary syndrome of menopause (VVA/GSM)

UR - http://www.scopus.com/inward/record.url?scp=85062320013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062320013&partnerID=8YFLogxK

U2 - 10.1080/14656566.2019.1582644

DO - 10.1080/14656566.2019.1582644

M3 - Editorial

AN - SCOPUS:85062320013

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

ER -